| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.03 | 0.6 |